|
|
|
|
|
|
|
|
|
27.01.26 - 21:09
|
Merck Announces Second-Quarter 2026 Dividend (Business Wire)
|
|
|
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.85 per share of the company's common stock for the second quarter of 2026. Payment will be made on April 7, 2026, to shareholders of record at the close of business on March 16, 2026.
About Merck
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly ever...
|
|
|
27.01.26 - 19:01
|
Merck & Co Aktie: Kursziel kräftig angehoben - doch droht jetzt kurzfristig Gegenwind? (Aktiencheck)
|
|
|
New York (www.aktiencheck.de) - Merck & Co-Aktienanalyse von Cantor Fitzgerald:
Cantor Fitzgerald habe das Kursziel für die Aktie von Merck & Co Inc. (ISIN: US58933Y1055, WKN: A0YD8Q, Ticker-Symbol: 6MK, NYSE-Symbol: MRK) von 83 auf 116 USD angehoben und das Votum "neutral" beibehalten. Die Kurzfrist-Prognose dürfte unter dem Konsens liegen und das könnte vorübergehend belastend wirken. [mehr]...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|